Schneider, Gisbert, 1965-....
Schneider, Gisbert
Gisbert Schneider German biochemist and bioinformatician and professor at ETH Zurich
Schneider, Götz 1965-
VIAF ID: 114184293 ( Personal )
Permalink: http://viaf.org/viaf/114184293
Preferred Forms
- 100 0 _ ‡a Gisbert Schneider ‡c German biochemist and bioinformatician and professor at ETH Zurich
- 200 _ | ‡a Schneider ‡b Gisbert ‡f 1965-....
-
- 100 1 _ ‡a Schneider, Gisbert
-
- 100 1 _ ‡a Schneider, Gisbert ‡d 1965-
- 100 1 _ ‡a Schneider, Gisbert ‡d 1965-
-
-
-
-
- 100 1 0 ‡a Schneider, Gisbert, ‡d 1965-
- 100 1 _ ‡a Schneider, Gisbert, ‡d 1965-....
- 100 1 _ ‡a Schneider, Götz ‡d 1965-
4xx's: Alternate Name Forms (5)
5xx's: Related Names (6)
- 551 _ _ ‡a Berlin ‡4 ortw ‡4 https://d-nb.info/standards/elementset/gnd#placeOfActivity
- 510 2 _ ‡a Eidgenössische Technische Hochschule Zürich ‡b Departement Chemie und Angewandte Biowissenschaften ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 551 _ _ ‡a Frankfurt am Main ‡4 ortw ‡4 https://d-nb.info/standards/elementset/gnd#placeOfActivity
- 510 2 _ ‡a Goethe-Universität Frankfurt am Main ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 510 2 _ ‡a Singapore-ETH Centre for Global Environmental Sustainability ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 551 _ _ ‡a Zürich ‡4 ortw ‡4 https://d-nb.info/standards/elementset/gnd#placeOfActivity
Works
Title | Sources |
---|---|
Acylanthranilamidderivate als Partialagonisten des Farnesoid X Rezeptors | |
Adaptive systems in drug design | |
Bioassays to monitor taspase1 function for the identification of pharmacogenetic inhibitors | |
Concepts in protein engineering and design : an introduction | |
Domain organization of long signal peptides of single-pass integral membrane proteins reveals multiple functional capacity | |
Immunrekonstitution nach allogener Stammzelltransplantation | |
Learning from nature: from a marine natural product to synthetic cyclooxygenase-1 inhibitors by automated de novo design | |
Merkmalsextraktion mitochondrialer Targetingsequenzen in Plasmodium falciparum | |
MHC I stabilizing potential of computer-designed octapeptides | |
Molecular design : concepts and applications | |
De novo molecular design, (Wiley-VCH) | |
plasmodium export element revisited | |
Prediction of extracellular proteases of the human pathogen Helicobacter pylori reveals proteolytic activity of the Hp1018/19 protein HtrA | |
Prediction of type III secretion signals in genomes of gram-negative bacteria | |
Protein-ligand interactions from molecular recognition to drug design | |
Sequential anti-cytomegalovirus response monitoring may allow prediction of cytomegalovirus reactivation after allogeneic stem cell transplantation | |
Spherical harmonics coeffcients for ligand-based virtual screening of cyclooxygenase inhibitors | |
Unraveling the activation mechanism of taspase1 which controls the oncogenic AF4–MLL fusion protein | |
Virtual screening for bioactive molecules |